Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran

BMC International Health and Human Rights

Volumn 5, Issue , 2005, Pages

  Nikfar, Shekoufeh ^a   Kebriaeezadeh, Abbas ^b   Majdzadeh, Reza ^b   Abdollahi, Mohammad ^b  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

CONTINUING EDUCATION; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG MONITORING; DRUG QUALITY; DRUG SAFETY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH STATUS; IRAN; MONITORING; NATIONAL DRUG POLICY; QUESTIONNAIRE; REVIEW; STANDARD; TECHNIQUE; WORLD HEALTH ORGANIZATION;

EID: 22544483573     PISSN: 1472698X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-698X-5-5     Document Type: Review

References (29)

1. World Health Organization: Constitution of the World Health Organization, including amendments adopted up to 31/12/2000 43rd edition. WHO Basic Document: Geneva; 2001.
2. General Assembly of the United Nations: Universal declaration of human rights. New York 1948.
3. United Nations Economic and Social Council: International covenant on economic, social and cultural rights. Geneva 1966.
4. United Nations Economic and Social Council. Committee on Economic, Social and Cultural Rights: Substantive issues arising in the implementation of the international covenant on economic, social and cultural rights. Geneva 2000.
5. World Health Organization: The selection of essential medicines. Geneva 2002.
6. Brudon-Jakobowicz P: Comparative analysis of national drug policies Geneva: World Health Organization; 1997.
7. World Health Organization: WHO medicines strategy. Framework for action in essential drugs and medicines policy 2002-2003. Geneva 2000.
8. World Health Organization: How to develop and implement a national drug Policy 2nd edition. WHO: Geneva; 2001.
9. Quick JD, Rankin JR, Laing RO, O'Connor RW, Hogerzeil HV, Dukes MNG, Garnett A: Managing Drug Supply 2nd edition. West Harford: Kumarian Press; 1997.
10. Management Sciences for Health: Rapid pharmaceutical management assessment: An indicator-based approach. Washington D.C 1995.
11. Brudon-Jakobowicz P, Rainhorn JD, Reich MR: Indicators for monitoring national drug policies, a practical manual 2nd edition. Geneva: World Health Organization; 1999.
12. Iran Statistics Center: Iran Statistics Center Publication. Tehran 2002.
13. Iran Central Bank [http://www.cbi.ir]
14. UNICEF: The State of the World's Children. Geneva 2003.
15. Sayari A: Health Statue Report of Iran Tehran: Iran MOH Publication; 2002.
16. Iran MOH (deputy of food and drug): Iran drug statistics annual report. Tehran 2002.
17. Nikfar S, Abdollahi M, Cheraghali A: A drug and poison information centre. Essent Drugs Monit 2000, 28&29:30-31.
18. Cheraghali A, Solymani F, Shalviri G: Promoting rational use activities in Iran. Essent Drugs Monit 2003, 33:10-11.
19. Iran MOH, Deputy of Food and Drug, Drug Regulatory Affairs: Guideline for accessibility to drugs out of Iran drug list. Tehran 2001.
20. Editorial: 25 years of essential medicines progress. Essent Drugs Monit 2003, 32:1-2.
21. Cheraghali AM, Nikfar S, Behanesh Y, Rahimi V, Habibipour F, Tirdad R: Evaluation of the pharmaceutical sector in Iran. East Mediterr Health J in press.
22. Laing R, Waning B, Gray A, Ford N, 't Hoen E: 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003, 361:1723-1729.
23. World Health Organization: How to investigate drug use in health facilities. Geneva 1993.
24. Quick JD, Hogerzeil HV, Velasquez G, Rago L: Twenty-five years of essential medicines. Bull World Health Organ 2002, 80:913-914.
25. World Health Organization: WHO model formulary. Geneva 2002.
26. World Health Organization: Drug price information services: what is WHO doing to improve drug price information? WHO fact sheet. Geneva 2002.
27. World Health Organization: Globalization, TRIPS and access to pharmaceuticals. Geneva 2002.
28. World Health Organization: The world health report 2000. Geneva 2000.
29. World Health Organization: The world drug situation. Geneva 1988.